Navigation Links
Angioplasty Equals Bypass Surgery for Heart Patients: Study
Date:10/16/2007

Survival rates virtually the same, but some people may prefer one option over the other

TUESDAY, Oct. 16 (HealthDay News) -- Someone with "mid-range" -- or intermediate -- coronary artery disease can use a new review of previous studies to help decide between angioplasty to open blocked arteries or bypass surgery to route new vessels around them, cardiologists say.

The long-term safety of the two procedures is just about the same, said study senior author Dr. Mark Hlatky, professor of health research and policy and cardiovascular medicine at Stanford University School of Medicine. Results for almost 10,000 patients from 23 clinical trials in the United States and Europe showed 98.2 percent survival for bypass surgery and 98.9 percent for angioplasty.

"But some people don't like the idea of major surgery and might want angioplasty," said Hlatky. "Others may want a more definitive treatment, with surgery more likely to relieve angina [chest pain] over a long period of time."

There was a lower chance of needing a repeat procedure for those who had surgery. Just under 10 percent of bypass patients had repeat procedures within five years, compared to 46.1 percent of those who had angioplasty without an implanted stent and 40.1 percent of those who had angioplasty with a stent.

But the reduction in repeat procedures came at the cost of increased risk of stroke. The stroke rate was 1.2 percent for those receiving bypass surgery versus 0.6 percent following angioplasty.

That increased stroke risk might make the difference for some people, said Dr. Deepak Bhatt, associate director of the Cleveland Clinic Cardiovascular Coordinating Center, since "many people would rather take the inconvenience of coming back rather than a higher risk of stroke."

Studies measuring quality of life found it was better for the three years following bypass surgery as compared to angioplasty. The difference disappeared after three years.

The point of the new study was to "give the full picture so that the patient and physician can come to the best decision about it," Hlatky said.

One important finding was that the overall survival rates for the two procedures were the same for people with diabetes. One previous study had found a significantly higher death rate for diabetics who had angioplasty, a result that immediately became controversial. The new study lessens the controversy but does not eliminate it entirely, Hlatky said.

"We were kind of surprised by that result," Hlatky said. "No one had sat down and put all the data together. But even in this analysis, the number of such patients was fairly small. The issue will be decided by ongoing trials for patients with diabetes."

A decision about angioplasty versus bypass surgery is always easier to make outside the middle range of coronary artery disease looked at in these trials, both Bhatt and Hlatky said. "For high-risk coronary artery syndromes, revascularization [surgery] in general is the right thing to do," Bhatt said.

And angioplasty would be the procedure of choice for those whose condition could no longer be managed with drug therapy, Hlatky said. "We reviewed data from people in the intermediate zone of coronary disease," he said.

The analysis did not include angioplasties in which drug-coated stents, introduced several years ago, were used, rather than bare-metal stents. Use of the newer stents should not change the picture dramatically, Hlatky said.

More information

Coronary artery disease and its treatments are described by the U.S. National Institutes of Health.



SOURCES: Mark Hlatky, M.D., professor of health research and policy, Stanford University School of Medicine, Stanford, Calif.; Deepak Bhatt, M.D., associate director, Cleveland Clinic Cardiovascular Coordinaing Center; Oct. 16, 2007, Annals of Internal Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Statins reduce risks for angioplasty patients
2. Cholesterol Drug Helps After Angioplasty
3. Angioplasty Should be the Standard
4. The Success Rate Of Angioplasty In Female Patients Low
5. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
6. Angioplasty death risk reduced by doubling drug dose
7. Angioplasty death risk reduced by doubling drug dose
8. A ray of hope in Angioplasty dilemma
9. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
10. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
11. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... (PRWEB) , ... May 28, 2016 , ... In a part of the city where’s ... city’s new farm-to-table Kelowna restaurants is hoping to attract diners with a taste ... & Suites officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing ...
(Date:5/27/2016)... Newark, NJ (PRWEB) , ... May 27, 2016 , ... ... been named as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The ... to their workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... needing intervention to walk, the demand for a sustainable product to aid in the ... void and aid in the recovery of individuals with hemiplegia due to stroke. , ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in the health ... of leaders in the nursing and health care industry. It also provides insight to ... Christian University. , As the nursing industry is coming out of one of ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on ... presentation entitled "High doses of biotin in progressive multiple sclerosis: ... by Professor Ayman Tourbah , Principal Investigator of the ... Academy of Neurology (EAN) in Copenhagen, Denmark ... take place on Sunday, 29 May 2016 from 14:45 to ...
Breaking Medicine Technology: